Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies
暂无分享,去创建一个
M. Koopmans | R. Scheuermann | J. Segalés | C. del Rio | M. Parrington | R. Schinazi | S. Weaver | J. Tartaglia | C. Bréchot | A. Garzino-Demo | A. Vahlne | A. Nitsche | W. Hall | A. Gessain | A. Abimiku | J. Osorio | R. L. Roper | S. Isaacs | S. Mahalingam | Robert C Gallo | A. Osterhaus | Linfa Wang | J. Esparza | G. McFadden | Tan Boon Huan | James LeDuc | Marvin Reitz | Marvin S. Reitz
[1] E. Mosites,et al. Possible Undetected Mpox Infection Among Persons Accessing Homeless Services and Staying in Encampments — San Francisco, California, October–November 2022 , 2023, MMWR. Morbidity and mortality weekly report.
[2] D. Vugia,et al. Use of Wastewater for Mpox Outbreak Surveillance in California. , 2023, The New England journal of medicine.
[3] G. La Rosa,et al. Detection of Monkeypox Virus DNA in Airport Wastewater, Rome, Italy , 2023, Emerging Infectious Diseases.
[4] Poonam Joshi,et al. Human-to-Human Transmission of Monkeypox Virus Old Virus with a New Face , 2022, Journal of Pure and Applied Microbiology.
[5] S. Chilimuri,et al. The use of vaccinia immune globulin in the treatment of severe mpox virus infection in HIV/AIDS. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] Matthew M. Cole,et al. Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[7] R. Scheuermann,et al. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans , 2022, Cell host & microbe.
[8] Todd G. Smith,et al. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo , 2022, Vaccine.
[9] D. Sano,et al. Multiple traces of monkeypox detected in non-sewered wastewater with sparse sampling from a densely populated metropolitan area in Asia , 2022, The Science of the total environment.
[10] A. Alcamí,et al. Spanish wastewater reveals the current spread of Monkeypox virus , 2022, medRxiv.
[11] M. Koopmans,et al. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals , 2022, Nature Medicine.
[12] L. Nolen,et al. High-Contact Object and Surface Contamination in a Household of Persons with Monkeypox Virus Infection — Utah, June 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[13] A. Lefranc,et al. First detection of Monkeypox virus genome in sewersheds in France , 2022, medRxiv.
[14] J. Doty,et al. Environmental Persistence of Monkeypox Virus on Surfaces in Household of Person with Travel-Associated Infection, Dallas, Texas, USA, 2021 , 2022, Emerging infectious diseases.
[15] E. Nicastri,et al. Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding , 2022, The Lancet. Infectious diseases.
[16] P. Ortiz-Romero,et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study , 2022, The Lancet.
[17] J. Koelewijn,et al. The detection of monkeypox virus DNA in wastewater samples in the Netherlands , 2022, The Science of the total environment.
[18] A. Antinori,et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. , 2022, The New England journal of medicine.
[19] M. Jonges,et al. Paediatric monkeypox patient with unknown source of infection, the Netherlands, June 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[20] D. Sobral,et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus , 2022, Nature Medicine.
[21] Emily Harris. What to Know About Monkeypox. , 2022, JAMA.
[22] Jennifer L. Small,et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK , 2022, The Lancet. Infectious diseases.
[23] F. Lienert,et al. The changing epidemiology of human monkeypox—A potential threat? A systematic review , 2021, medRxiv.
[24] Sinan Sousan,et al. SARS-CoV-2 Detection in air samples from inside heating, ventilation, and air conditioning (HVAC) systems- COVID surveillance in student dorms , 2021, American Journal of Infection Control.
[25] T. Yeo,et al. Imported Monkeypox, Singapore , 2020, Emerging infectious diseases.
[26] J. Dunning,et al. Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018 , 2020, Emerging infectious diseases.
[27] T. Senkevich,et al. Orthopoxvirus , 2020, Definitions.
[28] Anna M. Mandra,et al. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report , 2019, The Lancet. Infectious diseases.
[29] H. Achdout,et al. Diagnosis of Imported Monkeypox, Israel, 2018 , 2019, Emerging infectious diseases.
[30] A. Laudisoit,et al. Oral Tecovirimat for the Treatment of Smallpox. , 2018, The New England journal of medicine.
[31] Jennifer Wilburn,et al. Two cases of monkeypox imported to the United Kingdom, September 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[32] C. Tidona. The Springer Index of Viruses , 2018 .
[33] Y. Nakazawa,et al. Emergence of Monkeypox — West and Central Africa, 1970–2017 , 2018, MMWR. Morbidity and mortality weekly report.
[34] Z. Lobato,et al. Bovine Vaccinia: Insights into the Disease in Cattle , 2018, Viruses.
[35] Y. Nakazawa,et al. Characterization of Monkeypox virus infection in African rope squirrels (Funisciurus sp.) , 2017, PLoS neglected tropical diseases.
[36] T. Tippin,et al. Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies , 2016, Therapeutic drug monitoring.
[37] R. Holman,et al. Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox) , 2013, Antimicrobial Agents and Chemotherapy.
[38] G. Painter,et al. First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses , 2012, Antimicrobial Agents and Chemotherapy.
[39] M. Frace,et al. Vaccinia Virus Infections in Martial Arts Gym, Maryland, USA, 2008 , 2011, Emerging infectious diseases.
[40] Chelsea M. Byrd,et al. Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246 , 2009, Antimicrobial Agents and Chemotherapy.
[41] L. Mena,et al. Vulvar vaccinia infection after sexual contact with a smallpox vaccinee. , 2009, The American journal of the medical sciences.
[42] Chelsea M. Byrd,et al. ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification , 2009, Antimicrobial Agents and Chemotherapy.
[43] S. Weber,et al. Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment. , 2009, Vaccine.
[44] R. Buller,et al. Efficacy of therapeutic intervention with an oral ether–lipid analogue of cidofovir (CMX001) in a lethal mousepox model , 2007, Antiviral research.
[45] R. Jordan,et al. Synergistic Efficacy of the Combination of ST-246 with CMX001 against Orthopoxviruses , 2007, Antimicrobial Agents and Chemotherapy.
[46] D. Swerdlow,et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. , 2005, JAMA.
[47] C. Weiss,et al. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin. , 2005, Virology.
[48] D. Koelle,et al. Diversity in the Acute CD8 T Cell Response to Vaccinia Virus in Humans 1 2 , 2005, The Journal of Immunology.
[49] P. Jahrling,et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin , 2005, Virology.
[50] Pierre Baldi,et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] D. Tscharke,et al. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines , 2005, The Journal of experimental medicine.
[52] S. Davis,et al. Laboratory-Confirmed Transmission of Vaccinia Virus Infection through Sexual Contact with a Military Vaccinee , 2004, Journal of Clinical Microbiology.
[53] D. Swerdlow,et al. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. , 2004, Journal of the American College of Cardiology.
[54] S. Cinti,et al. Smallpox vaccination and adverse cardiac events. , 2004, Emerging infectious diseases.
[55] J. Guarner,et al. Monkeypox Transmission and Pathogenesis in Prairie Dogs , 2004, Emerging infectious diseases.
[56] K. Hostetler,et al. Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir , 2004, Antimicrobial Agents and Chemotherapy.
[57] Chris Upton,et al. JDotter: a Java interface to multiple dotplots generated by dotter , 2004, Bioinform..
[58] J. P. Davis,et al. The detection of monkeypox in humans in the Western Hemisphere. , 2004, The New England journal of medicine.
[59] S. Homann,et al. A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values. , 2003, The Pediatric infectious disease journal.
[60] Eric Gross. Update: multistate outbreak of monkeypox--Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. , 2003, MMWR. Morbidity and mortality weekly report.
[61] Rachel L. Roper,et al. Poxvirus Orthologous Clusters: toward Defining the Minimum Essential Poxvirus Genome , 2003, Journal of Virology.
[62] A. Kemper,et al. Expected adverse events in a mass smallpox vaccination campaign. , 2002, Effective clinical practice : ECP.
[63] B. Moss,et al. Envelope Formation Is Blocked by Mutation of a Sequence Related to the HKD Phospholipid Metabolism Motif in the Vaccinia Virus F13L Protein , 1999, Journal of Virology.
[64] P E Fine,et al. The transmission potential of monkeypox virus in human populations. , 1988, International journal of epidemiology.
[65] Vaccinia virus infection after sexual contact with a military smallpox vaccinee -Washington, 2010. , 2010, MMWR. Morbidity and mortality weekly report.
[66] Update: multistate outbreak of monkeypox--Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. , 2003, MMWR. Morbidity and mortality weekly report.
[67] D. Heymann,et al. Re-emergence of monkeypox in Africa: a review of the past six years. , 1998, British medical bulletin.
[68] C. Roth,et al. Human monkeypox -- Kasai Oriental, Democratic Republic of Congo, February 1996-October 1997. , 1997, MMWR. Morbidity and mortality weekly report.
[69] P. Ziegler,et al. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. , 1972, Bulletin of the World Health Organization.